back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-12-03 16:15 Tx date 2025-11-27 |
$NRX
NurExone Biologic Inc formerly, EnerSpar Corp |
Drucker, Yoram
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
$177,500
+250,000 vol $0.71 each |
600,000 | |
| Filed 2025-12-03 16:14 Tx date 2025-11-27 |
$NRX
NurExone Biologic Inc formerly, EnerSpar Corp |
Ovadya, Eran
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
$106,500
+150,000 vol $0.71 each |
500,000 | |
| Filed 2025-12-03 16:11 Tx date 2025-11-27 |
$NRX
NurExone Biologic Inc formerly, EnerSpar Corp |
Shaltiel, Lior
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
$106,500
+150,000 vol $0.71 each |
500,000 | |
| Filed 2025-12-03 15:42 Tx date 2025-11-26 |
$NRX
NurExone Biologic Inc formerly, EnerSpar Corp |
Drucker, Yoram
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
$177,500
+250,000 vol $0.71 each |
||
| Filed 2025-12-03 15:42 Tx date 2025-11-26 |
$NRX
NurExone Biologic Inc formerly, EnerSpar Corp |
Drucker, Yoram
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
$177,500
+250,000 vol $0.71 each |
600,000 | |
| Filed 2025-12-03 15:40 Tx date 2025-11-26 |
$NRX
NurExone Biologic Inc formerly, EnerSpar Corp |
Ovadya, Eran
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
$106,500
+150,000 vol $0.71 each |
||
| Filed 2025-12-03 15:40 Tx date 2025-11-26 |
$NRX
NurExone Biologic Inc formerly, EnerSpar Corp |
Ovadya, Eran
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
$106,500
+150,000 vol $0.71 each |
500,000 | |
| Filed 2025-12-03 15:38 Tx date 2025-11-26 |
$NRX
NurExone Biologic Inc formerly, EnerSpar Corp |
Shaltiel, Lior
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
$106,500
+150,000 vol $0.71 each |
500,000 | |
| Filed 2025-12-03 15:38 Tx date 2025-11-26 |
$NRX
NurExone Biologic Inc formerly, EnerSpar Corp |
Shaltiel, Lior
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
$106,500
+150,000 vol $0.71 each |
||
| Filed 2025-12-03 09:40 Tx date 2025-12-02 |
$NRX
NurExone Biologic Inc formerly, EnerSpar Corp |
Richardson, James Angus Wilson (Bilkstys-)
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,035
+1,500 vol $0.69 each |
178,274 | |
| Filed 2025-12-01 09:45 Tx date 2025-12-01 |
$NRX
NurExone Biologic Inc formerly, EnerSpar Corp |
Richardson, James Angus Wilson (Bilkstys-)
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,449
+5,000 vol $0.69 each |
176,774 | |
| Filed 2025-09-22 10:34 Tx date 2025-09-22 |
$NRX
NurExone Biologic Inc formerly, EnerSpar Corp |
Richardson, James Angus Wilson (Bilkstys-)
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,456
-1,400 vol $1.04 each |
171,774 | |
| Filed 2025-09-19 16:07 Tx date 2025-09-19 |
$NRX
NurExone Biologic Inc formerly, EnerSpar Corp |
Richardson, James Angus Wilson (Bilkstys-)
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,696
-1,600 vol $1.06 each |
173,174 | |
| Filed 2025-09-19 16:05 Tx date 2025-09-18 |
$NRX
NurExone Biologic Inc formerly, EnerSpar Corp |
Richardson, James Angus Wilson (Bilkstys-)
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,300
-5,000 vol $1.06 each |
174,774 | |
| Filed 2025-09-19 16:04 Tx date 2025-09-17 |
$NRX
NurExone Biologic Inc formerly, EnerSpar Corp |
Richardson, James Angus Wilson (Bilkstys-)
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-9,900
-9,000 vol $1.10 each |
179,774 | |
| Filed 2025-09-19 16:03 Tx date 2025-09-16 |
$NRX
NurExone Biologic Inc formerly, EnerSpar Corp |
Richardson, James Angus Wilson (Bilkstys-)
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-11,364
-12,000 vol $0.95 each |
188,774 | |
| Filed 2025-09-15 10:54 Tx date 2025-09-12 |
$NRX
NurExone Biologic Inc formerly, EnerSpar Corp |
Richardson, James Angus Wilson (Bilkstys-)
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,200
-8,000 vol $0.90 each |
208,774 | |
| Filed 2025-09-15 10:52 Tx date 2025-09-15 |
$NRX
NurExone Biologic Inc formerly, EnerSpar Corp |
Richardson, James Angus Wilson (Bilkstys-)
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,440
-8,000 vol $0.93 each |
200,774 | |
| Filed 2025-09-15 10:38 Tx date 2025-09-12 |
$NRX
NurExone Biologic Inc formerly, EnerSpar Corp |
Richardson, James Angus Wilson (Bilkstys-)
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,100
-9,000 vol $0.90 each |
||
| Filed 2025-09-12 09:40 Tx date 2025-09-11 |
$NRX
NurExone Biologic Inc formerly, EnerSpar Corp |
Richardson, James Angus Wilson (Bilkstys-)
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$10,935
+12,427 vol $0.88 each |
62,427 |